Aperam S.A. (LON:0OLF)
32.52
-0.44 (-1.33%)
At close: Dec 4, 2025
Aperam Market Cap
Aperam has a market cap or net worth of 2.08 billion as of December 4, 2025. Its market cap has increased by 29.10% in one year.
Market Cap
2.08B
Enterprise Value
3.01B
Revenue
5.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.52
Market Cap Chart
Since January 27, 2011, Aperam's market cap has decreased from 2.11B to 2.08B, a decrease of -1.22%. That is a compound annual growth rate of -0.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.06B | 36.78% |
| Dec 31, 2024 | 1.51B | -26.86% |
| Dec 29, 2023 | 2.06B | 4.13% |
| Dec 30, 2022 | 1.98B | -36.49% |
| Dec 31, 2021 | 3.12B | 27.38% |
| Dec 31, 2020 | 2.45B | 26.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| HSBC Holdings | 183.50B |
| Shell | 160.90B |
| Unilever | 110.86B |
| British American Tobacco p.l.c. | 94.42B |
| Rio Tinto Group | 93.84B |
| Rolls-Royce Holdings | 88.98B |
| GSK plc | 73.57B |